FDA Inspection
Axsome Therapeutics, Inc.Axsome Therapeutics, Inc. – FDA Inspection, Feb 6, 2026
Record Details
This FDA Inspection record concerns Axsome Therapeutics, Inc., with an inspection on February 6, 2026, issued by the New York District Office, covering human drugs.
View Company Profile
ID · d755cc61-e3b0-4906-a414-dc235848df39
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1301534
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring: Human Drugs
FDA Citations
2- 21 CFR 312.50General responsibilities of sponsors
- 21 CFR 312.56(b)Notification of FDA of termination of investigator
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Axsome Therapeutics, Inc.
1| Date | Classification | Office | Project area |
|---|---|---|---|
| July 1, 2021 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Axsome Therapeutics, Inc.
- FDA Inspection 1146168 - 2021-07-01
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.